TGF-β type I receptor inhibitor (TEW-7197) diminishes myeloma progression by multiple immunomodulatory mechanisms in combination with ixazomib

被引：1
|
作者：
Kim, Byung-Gyu
Sergeeva, Olga
Luo, George
Choi, Sung Hee
Lee, Zhenghong
Kim, Seong-Jin
Letterio, John
Malek, Ehsan
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-2647
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2647
引用
收藏
页数：2
相关论文
共 41 条
  • [1] Preclinical Studies and a Phase I Trial of the TGF-β Receptor Inhibitor, Vactosertib (TEW-7197), in Combination with Pomalidomide in Patients with Multiple Myeloma Refractory to Bortezomib or Lenalidomide
    Malek, Ehsan
    Kim, Byung-Gyu
    Valent, Jason
    Driscoll, James
    Caimi, Paolo
    Kim, Seong-Jin
    de Lima, Marcos
    Letterio, John
    BLOOD, 2018, 132
  • [2] Vactosertib, a TGF-β Receptor I Kinase/ALK5 Inhibitor, Diminishes Tumor Progression and Bone Disease in a Mouse Model of Multiple Myeloma and Overcomes Resistance to Proteasome Inhibitors
    Kim, Byung-Gyu
    Choi, Sung Hee
    Luo, George
    Sergeeva, Olga
    Lee, Zhenghong
    Driscoll, James
    de Lima, Marcos
    Beck, Rose
    Kim, Seong-Jin
    Letterio, John
    Malek, Ehsan
    BLOOD, 2018, 132
  • [3] The TGFβ type I receptor kinase inhibitor vactosertib in combination with pomalidomide in relapsed/refractory multiple myeloma: a phase 1b trial
    Malek, Ehsan
    Rana, Priyanka S.
    Swamydas, Muthulekha
    Daunov, Michael
    Miyagi, Masaru
    Murphy, Elena
    Ignatz-Hoover, James J.
    Metheny, Leland
    Kim, Seong Jin
    Driscoll, James J.
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [4] TGF-β receptor I kinase inhibitor downregulates cytokine secretion and multiple myeloma cell proliferation in the bone marrow microenvironment.
    Hayashi, T
    Hideshima, T
    Podar, K
    Munoz, O
    Richardson, P
    Hamasaki, M
    Ishitsuka, K
    Murphy, A
    McEnroe, G
    Chakravarty, S
    Dugar, S
    Higgins, LS
    Chauhan, D
    Anderson, KC
    BLOOD, 2003, 102 (11) : 388B - 388B
  • [5] TGF-β receptor I kinase inhibitor downregulates cytokine secretion and multiple myeloma cell growth in the bone marrow microenvironment.
    Hayashi, T
    Hideshima, T
    Podar, K
    Richardson, P
    Munoz, O
    Hamasaki, M
    Ishitsuka, K
    Yasui, H
    Murphy, A
    McEnroe, G
    Chakravarty, S
    Dugar, S
    Higgins, LS
    Chauhan, D
    Anderson, KC
    BLOOD, 2004, 104 (11) : 648A - 648A
  • [6] TGF-β Type I Receptor Kinase Inhibitor EW-7197 Suppresses Cholestatic Liver Fibrosis by Inhibiting HIF1α-Induced Epithelial Mesenchymal Transition
    Kim, Min-Jin
    Park, Sang-A
    Kim, Chun Hwa
    Park, So-Yeon
    Kim, Jung-Shin
    Kim, Dae-Kee
    Nam, Jeong-Seok
    Sheen, Yhun Yhong
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2016, 38 (02) : 571 - 588
  • [7] Enhancement of dendritic cell-based immunotherapy using a small molecule TGF-β receptor type I (TGF-βRI) kinase inhibitor
    Rausch, MP
    Mahadevan, D
    Akporiaye, ET
    JOURNAL OF IMMUNOTHERAPY, 2005, 28 (06) : 651 - 651
  • [8] Enhanced antitumor efficacy of folate-linked liposomal doxorubicin with TGF-β type I receptor inhibitor
    Taniguchi, Yukimi
    Kawano, Kumi
    Minowa, Takuya
    Sugino, Takashi
    Shimojo, Yuki
    Maitani, Yoshie
    CANCER SCIENCE, 2010, 101 (10) : 2207 - 2213
  • [9] Prevention Effect of TGF-β Type I Receptor Kinase Inhibitor in Esophageal Stricture Formation after Corrosive Burn
    Kim, Min-Tae
    Kim, Kun-Yung
    APPLIED SCIENCES-BASEL, 2021, 11 (23):
  • [10] Use of a TGFβ type I receptor inhibitor in mouse skin carcinogenesis reveals a dual role for TGFβ signaling in tumor promotion and progression
    Markell, Lauren Mordasky
    Perez-Lorenzo, Rolando
    Masiuk, Katelyn E.
    Kennett, Mary J.
    Glick, Adam B.
    CARCINOGENESIS, 2010, 31 (12) : 2127 - 2135
12345